Evidence map›Paper›PMID 33383838›Full record

ReviewInternational journal of molecular sciences2020

Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases.

Paweł Śledziński, Agnieszka Nowak-Terpiłowska, Joanna Zeyland

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. The impact of cannabis on immune checkpoint inhibitor therapy: a systematic review of immunomodulatory effects of cannabis in patients with and without cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. CNR1 and CNR2 Cannabinoid Receptor Mutations in Cancer Cells.Current issues in molecular biology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Characterization of the Antitumor Potential of Extracts ofInternational journal of molecular sciences · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Cannabidiol and SARS-CoV-2 Infection.Frontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Paweł ŚledzińskiDepartment of Genome Engineering, Institute of Bioorganic Chemistry, Polish Academy of Sciences, 60-032 Poznan, Poland.ORCID 0000-0002-4671-5189
Agnieszka Nowak-TerpiłowskaDepartment of Biochemistry and Biotechnology, Poznan University of Life Sciences, 60-632 Poznan, Poland.
Joanna ZeylandDepartment of Biochemistry and Biotechnology, Poznan University of Life Sciences, 60-632 Poznan, Poland.ORCID 0000-0002-1208-3291
University of Life Sciences in Poznań · PLInstitute of Bioorganic Chemistry, Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, there has been a growing interest in the medical applications of

Indexed as

AnimalsAnti-Infective AgentsAntineoplastic Agents, PhytogenicApoptosisCannabinoidsCannabisChemistry Techniques, SyntheticCommunicable DiseasesHumansImmune SystemImmunologic FactorsNeoplasmsReceptors, CannabinoidAnti-Infective AgentsAntineoplastic Agents, PhytogenicCannabinoidsImmunologic FactorsReceptors, Cannabinoidcancer medicinecannabinoid receptorscannabinoidsimmune medicine

Identifiers

PMID33383838
PMCPMC7795897
OpenAlexW3116601020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.